BCHE and Alzheimer disease: There is a pressing need for a novel approach to Alzheimer’s disease (AD) therapy, given that the existing therapeutic choices, such as memantine and cholinesterase inhibitors, solely address the symptoms of the disease without targeting its fundamental causes of progression [10, 11].